![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Giannoukakis Nick
Publisher: Future Medicine
ISSN: 1750-743X
Source: Immunotherapy, Vol.5, Iss.6, 2013-06, pp. : 569-571
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The potential role of dendritic cells in the therapy of Type 1 diabetes
By Lee Chin-Nien Lew Andrew M Wu Li
Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells
By Ichim T.E. Zhong R. Min W.-P.
Transplant Immunology, Vol. 11, Iss. 3, 2003-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Li Mu Zhang Xusheng Zheng Xiufen Lian Dameng Zhang Zhu-Xu Sun Hongtao Suzuki Motohiko Vladau Costin Huang Xuyan Xia Xiaoping Zhong Robert Garcia Bertha Min Wei-Ping
International Immunology, Vol. 20, Iss. 2, 2008-02 ,pp. :